AFIB — Acutus Medical, Inc.
$0.00
+$0.00 (+0.00%)
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
Market Cap
$2991.00
Forward P/E
-0.0x
52-Week Range
N/A
AFIB Price History
Revenue vs. Net Income
$16.4M
Revenue · FY2022
Annual. Net margin is shown under each year.
Free Cash Flow
-$89.1M
FCF · FY2022
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
29.9%
ROCE · FY2022
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.3x
Assets ÷ liabilities · FY2022
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
1.4%
CapEx · FY2022
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-1.2%
Net buyback · FY2022
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
